Inflammation is a central driver of chronic disease, from arthritis and cardiovascular dysfunction to metabolic disorders and neurodegenerative conditions. Two compounds with robust evidence for anti-inflammatory effects are curcumin, a polyphenol extracted from turmeric, and melatonin, the endogenous sleep hormone increasingly studied for systemic health benefits beyond circadian regulation.
Both compounds demonstrate Tier 4 evidence for anti-inflammatory efficacy—the highest category—with consistent reductions in key inflammatory markers across multiple meta-analyses of randomized controlled trials (RCTs). However, they work through distinct mechanisms, have different optimal dosing ranges, and may be more suitable for different populations and inflammatory conditions.
This comparison examines the evidence specifically for anti-inflammatory benefits, helping you understand which may be the better choice for your needs.
| Attribute | Curcumin | Melatonin |
|---|
| Evidence Tier | Tier 4 (Strong) | Tier 4 (Strong) |
| Primary Anti-Inflammatory Mechanism | NF-κB inhibition, ROS scavenging, COX-2/LOX modulation | Direct free radical scavenging, antioxidant enzyme upregulation, immunomodulation |
| CRP Reduction | -0.58 mg/L (66 RCTs) | -0.59 mg/L (63 RCTs) |
| TNF-α Reduction | -3.48 pg/mL (66 RCTs) | -1.61 to -2.24 pg/mL (13-63 RCTs) |
| IL-6 Reduction | -1.31 pg/mL (66 RCTs) | -6.43 to -30.25 pg/mL (13-63 RCTs) |
| Typical Dose | 500-1000 mg twice daily | 5 mg once daily (for anti-inflammation) |
| Side Effects | GI discomfort, bleeding risk, iron chelation | Morning grogginess, vivid dreams, dizziness |
| Monthly Cost | $10-$55 | $4-$20 |
| Best For | Joint pain, digestive inflammation, chronic inflammatory conditions | Sleep-related inflammation, circadian dysfunction, metabolic syndrome |
Curcumin's anti-inflammatory power stems from its ability to inhibit NF-κB signaling, a master regulator that controls the expression of pro-inflammatory genes. When NF-κB is suppressed, cells produce fewer inflammatory cytokines—the chemical messengers that perpetuate inflammation throughout the body.
Beyond NF-κB blockade, curcumin also:
- Scavenges reactive oxygen species (ROS), neutralizing free radicals that trigger inflammatory cascades
- Upregulates Nrf2 pathways, boosting the body's endogenous antioxidant defenses
- Modulates COX-2 and LOX enzymes, reducing prostaglandin production (similar to how NSAIDs work, but via a different pathway)
- Influences AMPK activation, connecting inflammation reduction to metabolic improvements
This multitarget approach makes curcumin effective across diverse inflammatory conditions.
The evidence for curcumin is remarkably robust. A meta-analysis of 66 RCTs (Dehzad et al.) found:
- CRP reduction: -0.58 mg/L (95% CI: -0.74, -0.41, p<0.05)
- TNF-α reduction: -3.48 pg/mL (95% CI: -4.38, -2.58, p<0.05)
- IL-6 reduction: -1.31 pg/mL (95% CI: -1.58, -0.67, p<0.05)
A larger analysis of 103 RCTs (7,216 participants) confirmed high-quality evidence for improving CRP and other inflammatory markers, with 55% of 42 measured health outcomes reaching statistical significance.
Curcumin's anti-inflammatory effects translate to real-world clinical benefits:
- Osteoarthritis: A meta-analysis of 11 RCTs showed curcumin significantly reduced WOMAC pain and stiffness scores and VAS pain in osteoarthritis patients.
- Rheumatoid arthritis: In women with RA (n=48, 8-week RCT), 500 mg/day curcumin decreased tender joint count, swollen joint count, and disease activity scores compared to placebo (p<0.001).
- Metabolic inflammation: Multiple RCTs demonstrate reductions in inflammatory markers in patients with metabolic syndrome, NAFLD, and diabetes.
While melatonin is famous for regulating sleep through MT1 and MT2 receptor activation in the brain, its anti-inflammatory benefits operate through distinct pathways:
- Direct free radical scavenging: Melatonin is a lipophilic and hydrophilic antioxidant that crosses cellular membranes and the blood-brain barrier to neutralize ROS directly
- Antioxidant enzyme upregulation: Melatonin increases superoxide dismutase (SOD) and glutathione peroxidase (GPx), strengthening intrinsic cellular defenses
- Circadian modulation of immunity: By restoring healthy circadian rhythms, melatonin reduces systemic inflammation driven by circadian dysregulation—a major factor in chronic disease
The circadian mechanism is particularly important: disrupted sleep schedules amplify inflammation through shifts in immune cell trafficking and cytokine production. By improving sleep quality and circadian alignment, melatonin may reduce inflammation at the systems level.
Melatonin's anti-inflammatory evidence is equally strong. A meta-analysis of 63 RCTs (Mohammadi et al.) found:
- CRP reduction: -0.59 mg/L (virtually identical to curcumin)
- TNF-α reduction: -1.61 pg/mL
- IL-6 reduction: -6.43 pg/mL
A second meta-analysis of 13 studies (n=749) reported:
- TNF-α reduction: -2.24 pg/mL (95% CI -3.45, -1.03; p<0.001)
- IL-6 reduction: -30.25 pg/mL (95% CI -41.45, -19.06; p<0.001)
An RCT in diabetic CKD patients (n=41) using 5 mg melatonin twice daily for 10 weeks decreased high-sensitivity CRP, MDA, and TOS with no adverse effects.
The anti-inflammatory benefits of melatonin extend to specific disease populations:
- Metabolic syndrome and diabetes: Melatonin reduces inflammatory markers and cardiometabolic risk factors, with larger effects in metabolic disorder patients.
- Autoimmune conditions: In SLE patients, melatonin 10 mg/day for 12 weeks reduced oxidative stress markers (MDA) by 33% versus baseline (p=0.003).
- Sleep-dependent inflammation: By improving sleep quality, melatonin indirectly reduces the chronic inflammation driven by poor sleep, which affects immune function across 24-hour cycles.
Both compounds have equally strong evidence for anti-inflammatory efficacy, supported by large meta-analyses (63-66 RCTs each) and consistent reductions in the three primary inflammatory markers: CRP, TNF-α, and IL-6.
CRP: The effect sizes are virtually identical (curcumin -0.58 vs melatonin -0.59 mg/L).
TNF-α: Curcumin shows a larger reduction (-3.48 pg/mL) compared to melatonin (-1.61 to -2.24 pg/mL)—approximately 40-50% greater effect.
IL-6: Melatonin shows a larger reduction (-6.43 to -30.25 pg/mL) compared to curcumin (-1.31 pg/mL)—approximately 5-23 times greater effect.
This divergence is important: if TNF-α dominates your inflammatory profile, curcumin may be superior. If IL-6 is elevated, melatonin may offer greater benefit. Many individuals have mixed inflammatory phenotypes, suggesting combination therapy could be synergistic.
- Curcumin targets inflammatory gene transcription upstream (NF-κB blockade), preventing the production of inflammatory mediators at the source.
- Melatonin works downstream and circadian-level, scavenging ROS and supporting the antioxidant machinery that dampens inflammation.
These complementary mechanisms suggest they may work synergistically rather than redundantly.
- Curcumin evidence spans diverse inflammatory conditions: arthritis, metabolic disorders, cardiovascular disease, and even neuroinflammation.
- Melatonin evidence is more concentrated in disease-specific populations (diabetes, metabolic syndrome, multiple sclerosis, autoimmune conditions), with stronger emphasis on sleep-related inflammation.
- Oral: 500-1000 mg twice daily (typical anti-inflammatory range)
- Bioavailability caveat: Curcumin alone has poor absorption (~1% bioavailability). Formulations with piperine (black pepper extract) or phospholipid delivery (phytosomal curcumin) dramatically improve absorption and reduce the required dose.
- Optimal duration: Benefits accumulate over 8-12 weeks; most RCTs show stronger effects at longer durations.
- Oral: 5-20 mg once daily (for anti-inflammatory effects; lower doses are used for sleep)
- Timing: Evidence suggests evening administration to leverage circadian synchronization.
- Duration: Anti-inflammatory effects emerge within 4-12 weeks in most studies.
Key difference: Curcumin requires higher absolute doses (500-2000 mg/day) with bioavailability limitations, while melatonin achieves anti-inflammatory effects at lower doses (5-20 mg/day).
Curcumin is generally recognized as safe (GRAS) by the FDA up to 8 g/day in short-term studies. Common side effects at higher doses include:
- Gastrointestinal discomfort (nausea, bloating, diarrhea >2 g/day)
- Mild antiplatelet activity (increased bleeding risk)
- Iron chelation with very high chronic doses
- Yellow staining of stool, skin, and clothing
Cautions: Those on anticoagulants, with gallbladder disease, or pregnant individuals should consult a healthcare provider.
Melatonin has an excellent short-term safety profile and is one of the most widely used sleep supplements globally. Common side effects include:
- Morning grogginess or next-day sedation (especially >3 mg)
- Dizziness or lightheadedness
- Headache, vivid dreams, nausea
Cautions: Long-term effects at pharmacological doses remain understudied. Use with caution in children, pregnant/breastfeeding individuals, and those with autoimmune conditions (melatonin modulates immune function).
Verdict: Both are well-tolerated. Curcumin poses a bleeding risk for anticoagulant users; melatonin's main concern is long-term safety data and immune modulation in autoimmune disease.
- Curcumin: $10-$55/month (varies widely by formulation and bioavailability enhancement)
- Melatonin: $4-$20/month
Melatonin is significantly cheaper, though premium bioavailable formulations of curcumin may offer better value per unit of absorption.
- You have joint pain or arthritis (OA/RA)—evidence is especially robust here
- You want to target TNF-α specifically (curcumin's largest effect)
- You have digestive inflammation or NAFLD
- You're seeking multi-system anti-inflammatory and antioxidant benefits (curcumin has additional evidence for cognition, mood, and longevity)
- You have normal or low bleeding risk
- You have elevated IL-6 or sleep-dependent inflammation
- You have circadian dysfunction or poor sleep quality driving inflammation
- You have metabolic syndrome or diabetes with inflammatory markers
- You're on anticoagulant medications (curcumin's bleeding risk is a contraindication)
- You have cost concerns (melatonin is cheaper)
- You're seeking additional sleep and recovery benefits beyond anti-inflammation
- You have moderate-to-severe systemic inflammation across multiple markers
- You want to target TNF-α and IL-6 simultaneously
- You have the budget and tolerance for dual supplementation
- Your inflammation is driven by both joint/metabolic dysfunction AND circadian misalignment
The complementary mechanisms (transcriptional blockade vs. antioxidant support) suggest potential synergy, though no RCT has directly tested the combination.
Both curcumin and melatonin have Tier 4 evidence for anti-inflammatory efficacy, supported by large meta-analyses showing consistent reductions in CRP, TNF-α, and IL-6. The choice between them depends on your inflammatory profile, existing conditions, medication interactions, and treatment goals.
Curcumin is the stronger choice for joint-related inflammation and TNF-α reduction, with a broader track record across inflammatory conditions. However, it requires higher doses, has potential GI side effects, and poses a bleeding risk for those on anticoagulants.
Melatonin offers superior IL-6 reduction, lower cost, better safety for anticoagulant users, and added benefits for sleep-driven inflammation. It's ideal if circadian dysfunction is contributing to your inflammatory burden.
Both are evidence-based, well-tolerated, and reasonably priced. The best choice is the one that aligns with your specific inflammatory markers, health conditions, medications, and lifestyle factors.
Disclaimer: This article is for educational purposes only and does not constitute medical advice. Before starting any new supplement, consult with a qualified healthcare provider, especially if you have existing health conditions, take medications (particularly anticoagulants or immunosuppressants), or are pregnant or breastfeeding. Individual responses to supplements vary, and this comparison reflects population-level evidence that may not apply to every person.